Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage

Hepatology

Volumn 24, Issue 3, 1996, Pages 494-501

  Lindh, Magnus ^a   Horal, Peter ^a   Dhillon, Amar P ^b   Furuta, Yasushi ^a,c   Norkrans, Gunnar ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ANTIGEN DETECTION; ARTICLE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS DETECTION; VIRUS MUTATION;

EID: 0029844860     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781313     Document Type: Article

References (51)

1. Magnius L, Espmark Å. A new antigen complex co-occurring with australia antigen. Acta Path Microbiol Scand 1972;80:335-337.
2. Okada K, Kamiyama I, Inomata M, Mitsunobu I, Miyakawa Y, Mayumi M. e antigen and anti-e in serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-749.
3. Sheikh NEL, Woolf IL, Galbraith RM, Eddleston ALWF, Dymock IW, Williams R. e antigen-antibody system as indicator of liver damage in patients with hepatitis B antigen. Br Med J 1975;4:252-253.
4. Realdi G, Alberti A, Rugge M, Bortolotti F, Rigoli AM, Tremolada F, Ruol A. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-199.
5. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones A, Waggoner JG, Bales ZB. Seroconversion from hepatitis B antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-748.
6. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and HBV DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. HEPATOLOGY 1983;3:656-662.
7. Liaw YF, Chu CM, Lin DY, Sheen IS, Yang CY, Huang MJ. Age specific prevalence and significance of HBe antigen and antibody in chronic hepatitis B virus infection in Taiwan. J Med Virol 1984;13:385-391.
8. Karayiannis P, Fowler MJ, Lok AS, Greenfield C, Monjardino J, Thomas HC. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985;1:99-106.
9. Brunetto MR, Stemler M, Schödel F, Will H, Ottobrelli A, Rizzetto M, Verme G, et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989;21:151-154.
10. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of HBeAg in patients with chronic hepatitis B infection. Lancet 1989;2:588-591.
11. Ferrari C, Penna A, Bertoletti A, Fiaccadori F. Cell mediated immune response to hepatitis B virus nucleocapsid antigen. Arch Virol Suppl 1993; 8:91-101.
12. Tsai SL, Chen MY, Yang PM, Sung JL, Hwang LH, Chang TH, Chen TS. Acute exacerbations of chronic hepatitis B are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 1992;89: 87-93.
13. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during Seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 1995;69: 3358-3368.
14. Tong SP, Li JS, Vitvitski L, Trepo C. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal. Virology 1992;191:237-245.
15. Tong SP, Li JS, Vitvitski L, Kay A, Trepo C. Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J Virol 1993;67:5651-5655.
16. Pollack JR, Ganem D. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol 1993;67:3254-3263.
17. Wang GH, Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 1993;67:6407-6512.
18. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993;67:5402-5410.
19. Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 1994;91:4077-4081.
20. Lindh M, Furuta Y, Vahlne A, Norkrans G, Horal P. Emergence of hepatitis B precore TAG stop codon mutation during HBe seroconversion and its dependence on the pregenomic basepairing between nucleotides 1858 and 1896. J Infect Dis 1995;172:1343-1347.
21. Brunetto MR, Stemler M, Bonino F, Oliveri F, Rizetto M, Verme G, Will H. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 1990;10:258-261.
22. Liang TJ, Hasegawa K, Rimon N, Wands JR, Pen-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991;324:1705-1709.
23. Yotsumoto S, Kojima M, Shoji I, Yamamoto K, Okamoto H, Mishiro S. Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses. HEPATOLOGY 1992;16:31-35.
24. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, Tsuda F, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995;122: 241-248.
25. Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. HEPATOLOGY 1995; 21:14-18.
26. Brunetto MR, Giarin M, Saracco G, Olivero F, Calvo P, Capra G, Randone A, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993;105:845-850.
27. Lok AS, Akarca US, Greene S. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance. HEPATOLOGY 1995;21:19-24.
28. Tur-Kaspa R, Klein A, Aharanson S. HBV precore mutants are identical in carriers from various ethnic origins and associated with a range of liver disease severity. HEPATOLOGY 1992;16:1338-1342.
29. Lai ME, Solinas A, Mazzoleni AP, Deplano A, Farci P, Lisci V, Porru A, et al. The role of hepatitis B virus mutants on the long term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. J Hepatol 1994; 20:773-781.
30. Akarca US, Greene S, Lok AS. Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family members. HEPATOLOGY 1994;19:1366-1370.
31. Hamasaki K, Nakata K, Nagayama Y, Ohtsuru A, Daikoku M, Taniguchi K, Tsutsumi T, et al. Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B. HEPATOLOGY 1994:8-14.
32. Raimondo G, Meucci G, Sardo MA, Rodinò G, Campo S, Vecchi M, Pernice M, et al. Persistence of "wild type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers. J HEPATOL 1994; 20:148-151.
33. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64:1298-1303.
34. Tong SP, Li J, Vitvitski L, Trepo C. Active hepatitis B virus replication in the presence of viral variants containing an inactive pre-C region. Virology 1990;176:596-603.
35. Rodriguez-Frias F, Buti M, Jardi R, Cotrina M, Viladomiu L, Esteban R, Guardia J. Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. HEPATOLOGY 1995;22:1641-1647.
36. Miska S, Gunther S, Vassilev M, Meisel H, Pape G, Will H. Heterogeneity of hepatitis B C-gene sequences: implications for amplification and sequencing. J Hepatol 1993;18:53-61.
37. Blum HE, Galun E, Liang TJ, von Weizsäcker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991;65:1836-1842.
38. Lindh M, Furuta Y, Kidd-Ljunggren K, Norkrans G, Horal P. Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method. J Infect Dis 1995;171:194-197.
39. Daikoku M, Nakata K, Hamasaki K, Ido A, Nakao K, Kato Y, Koga M, et al. Analysis of wild-type and e antigen-defective hepatitis B viruses during the course of a short-term corticosteroid therapy in chronic hepatitis B. J Med Virol 1995;47:184-188.
40. Knodell RG, Ishak KG, Black WC, Chen TC, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
41. Lindh M, Norkrans G, Stenqvist K, Eriksson K, Taranger J. Hepatits B carriers in Sweden - effects of immigration. Scand J Infect Dis 1993;25: 411-416.
42. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, et al. Hepatitis B virus with mutations in the core promotor for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-8110.
43. Ou JH, Laub O, Rutter WJ. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A 1986;83:1578-1582.
44. Löhr HF, Weber W, Schlaak J, Goergen B, Meyer zum Büchenfelde KH, Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. HEPATOLOGY 1995;22:61-68.
45. Milich DR, Peterson DL, Schodel F, Jones JE, Hughes JL. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol 1995;69: 2776-2785.
46. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
47. Barnaba V, Franco A, Paroli M, Benvenuto R, De PG, Burgio VL, Santilio I, et al. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994;152:3074-3087.
48. Laskus T, Rakela J, Persing DH. The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants. Virology 1994;200:809-812.
49. Günther S, Meisel H, Reip A, Miska S, Krüger DH, Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 1992;187:271-279.
50. Will H, Reiser T, Weimer T, Pfaff E, Bücher M, Sprengel R, Catteaneo R, et al. Replication strategy of hepatitis B viruses. J Virol 1987;61:904-911.
51. Gerken G, Paterlini P, Manns M, Housset C, Terre S, Dienes HP, Hess G, et al. Assay of HBV DNA by PCR and its relationship to pre-S- and S-encoded surface antigens. HEPATOLOGY 1991;13:158-166.